Tissue Therapies
HOME TECHNOLOGY INVESTORS ALLIANCES COMPANY
CONTACT


Tissue Therapies Limited provides wound healing, tissue repair and cell culture technology through a novel growth factor platform technology, VitroGro®  


VitroGro® is an animal product free, mulitimeric delivery system for growth factors, enhancing cell replication, protein synthesis and migration.
 
7 Jan 2010
Human Trial of VitroGro: Prof Keith Harding, Cardiff University [PDF]

7 Dec 2009
Share Purchase Plan Closes Oversubscribed [PDF]

27 Nov 2009
CEO AGM Presentation [PDF]

 
 
 

VitroGro® is available as a coating kit for in vitro mammalian cell culture research purposes and evaluation by interested scientists and potential collaborators and commercials partners or customers following signing of a Materials Transfer Agreement.

The management and technical team of Tissue Therapies are highly qualified and experienced.

Tissue Therapies current share price is available on the ASX.
     
 

27 Nov 2009
Chairman’s 2009 AGM Address [PDF]

26 Nov 2009
 Second Core VitroGro® Patent Granted in Australia [PDF] .
25 Nov 2009
Second VitroGro Patent Allowed in USA [PDF]

23 Nov 2009
Shareholder Newsletter [PDF]

 
 

Tissue Therapies forms alliances with strategic partners worldwide

  
© 2007 TISSUE THERAPIES LTD